# RDF export of group: Publication
<http://ctro/data#Publication_46459> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Publication> .
<http://ctro/data#Publication_46459> <http://www.w3.org/2000/01/rdf-schema#label> "Publication 46459" .
<http://ctro/data#Publication_46459> <http://ctro/data#hasTitle> "Linagliptin for patients aged 70 years or older with type 2 diabetes inadequately controlled with common antidiabetes treatments : a randomised , double - blind , placebo - controlled trial ." .
<http://ctro/data#Publication_46459> <http://ctro/data#hasAuthor> "Barnett AH" .
<http://ctro/data#Publication_46459> <http://ctro/data#hasPublicationYear> "2013" .
<http://ctro/data#Publication_46459> <http://ctro/data#hasJournal> "Lancet" .
<http://ctro/data#Publication_46459> <http://ctro/data#hasPMID> "23948125" .
<http://ctro/data#Publication_46459> <http://ctro/data#describes> <http://ctro/data#ClinicalTrial_46466> .
<http://ctro/data#Publication_46459> <http://ctro/data#hasAuthor> "Huisman H" .
<http://ctro/data#Publication_46459> <http://ctro/data#hasAuthor> "Jones R" .
<http://ctro/data#Publication_46459> <http://ctro/data#hasAuthor> "von Eynatten M" .
<http://ctro/data#Publication_46459> <http://ctro/data#hasAuthor> "Patel S" .
<http://ctro/data#Publication_46459> <http://ctro/data#hasAuthor> "Woerle HJ" .
# RDF export of group: ClinicalTrial
<http://ctro/data#ClinicalTrial_46466> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#ClinicalTrial> .
<http://ctro/data#ClinicalTrial_46466> <http://www.w3.org/2000/01/rdf-schema#label> "ClinicalTrial 46466" .
<http://ctro/data#ClinicalTrial_46466> <http://ctro/data#hasObjectiveDescription> "We aimed to assess the effectiveness of linagliptin , a dipeptidyl peptidase - 4 inhibitor , in elderly patients with type 2 diabetes ." .
<http://ctro/data#ClinicalTrial_46466> <http://ctro/data#hasNumberPatientsCT> "241" .
<http://ctro/data#ClinicalTrial_46466> <http://ctro/data#hasCTduration> "24 weeks" .
<http://ctro/data#AllocationRatio_46470> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#AllocationRatio> .
<http://ctro/data#ClinicalTrial_46466> <http://ctro/data#hasAllocationRatio> <http://ctro/data#AllocationRatio_46470> .
<http://ctro/data#CTAnalysisApproach_46471> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#CTAnalysisApproach> .
<http://ctro/data#ClinicalTrial_46466> <http://ctro/data#hasCTDesign> <http://ctro/data#Randomized> .
<http://ctro/data#ClinicalTrial_46466> <http://ctro/data#hasConclusionComment> "In elderly patients with type 2 diabetes linagliptin was efficacious in lowering glucose with a safety profile similar to placebo ." .
<http://ctro/data#ClinicalTrial_46466> <http://ctro/data#hasArm> <http://ctro/data#Arm_46555> .
<http://ctro/data#ClinicalTrial_46466> <http://ctro/data#analysesHealthCondition> <http://ctro/data#Type2Diabetes> .
<http://ctro/data#ClinicalTrial_46466> <http://ctro/data#hasPopulation> <http://ctro/data#Population_46482> .
<http://ctro/data#ClinicalTrial_46466> <http://ctro/data#hasDiffBetweenGroups> <http://ctro/data#DiffBetweenGroups_46801> .
<http://ctro/data#EvidenceQuality_46478> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#EvidenceQuality> .
<http://ctro/data#ClinicalTrial_46466> <http://ctro/data#hasCTDesign> <http://ctro/data#DoubleBlind> .
<http://ctro/data#ClinicalTrial_46466> <http://ctro/data#hasCTDesign> <http://ctro/data#Parallel> .
<http://ctro/data#ClinicalTrial_46466> <http://ctro/data#hasCTDesign> <http://ctro/data#Multicenter> .
<http://ctro/data#ClinicalTrial_46466> <http://ctro/data#hasConclusionComment> "These findings could inform treatment decisions for achieving individualised glycaemic goals with minimal risk in this important population of patients ." .
<http://ctro/data#ClinicalTrial_46466> <http://ctro/data#hasArm> <http://ctro/data#Arm_46568> .
# RDF export of group: Population
<http://ctro/data#Population_46482> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Population> .
<http://ctro/data#Population_46482> <http://www.w3.org/2000/01/rdf-schema#label> "Population 46482" .
<http://ctro/data#Population_46482> <http://ctro/data#hasPrecondition> "inadequately controlled with common antidiabetes treatments" .
<http://ctro/data#Ethnicity_46484> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Ethnicity> .
<http://ctro/data#Population_46482> <http://ctro/data#hasCountry> <http://ctro/data#UK> .
<http://ctro/data#Population_46482> <http://ctro/data#hasAvgAge> "74 · 9 years" .
<http://ctro/data#Gender_46489> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Gender> .
<http://ctro/data#Population_46482> <http://ctro/data#hasPrecondition> "patients aged 70 years or older with type 2 diabetes , glycated haemoglobin A1c ( HbA1c ) of 7 · 0 % or more , receiving metformin , sulfonylureas , or basal insulin , or combinations of these drugs" .
# RDF export of group: Endpoint
<http://ctro/data#Endpoint_46591> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Endpoint> .
<http://ctro/data#Endpoint_46591> <http://www.w3.org/2000/01/rdf-schema#label> "hba" .
<http://ctro/data#Endpoint_46591> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#HbA1c> .
<http://ctro/data#Mean_46593> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Mean> .
<http://ctro/data#Endpoint_46591> <http://ctro/data#hasAggregationMethod> <http://ctro/data#Mean_46593> .
<http://ctro/data#Endpoint_46591> <http://ctro/data#hasBaselineUnit> <http://ctro/data#Percentage> .
<http://ctro/data#MeasurementDevice_46595> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#MeasurementDevice> .
<http://ctro/data#Endpoint_46623> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Endpoint> .
<http://ctro/data#Endpoint_46623> <http://www.w3.org/2000/01/rdf-schema#label> "ae" .
<http://ctro/data#EndPointDescription_46624> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#EndPointDescription> .
<http://ctro/data#Endpoint_46623> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#EndPointDescription_46624> .
<http://ctro/data#AggregationMethod_46625> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#AggregationMethod> .
<http://ctro/data#BioAndMedicalUnit_46626> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#BioAndMedicalUnit> .
<http://ctro/data#MeasurementDevice_46627> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#MeasurementDevice> .
<http://ctro/data#Endpoint_46682> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Endpoint> .
<http://ctro/data#Endpoint_46682> <http://www.w3.org/2000/01/rdf-schema#label> "sea" .
<http://ctro/data#EndPointDescription_46683> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#EndPointDescription> .
<http://ctro/data#Endpoint_46682> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#EndPointDescription_46683> .
<http://ctro/data#AggregationMethod_46684> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#AggregationMethod> .
<http://ctro/data#BioAndMedicalUnit_46685> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#BioAndMedicalUnit> .
<http://ctro/data#MeasurementDevice_46686> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#MeasurementDevice> .
<http://ctro/data#Endpoint_46742> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Endpoint> .
<http://ctro/data#Endpoint_46742> <http://www.w3.org/2000/01/rdf-schema#label> "hyp" .
<http://ctro/data#Endpoint_46742> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#Hypoglycemia> .
<http://ctro/data#AggregationMethod_46744> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#AggregationMethod> .
<http://ctro/data#BioAndMedicalUnit_46745> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#BioAndMedicalUnit> .
<http://ctro/data#MeasurementDevice_46746> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#MeasurementDevice> .
# RDF export of group: Arm
<http://ctro/data#Arm_46555> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Arm> .
<http://ctro/data#Arm_46555> <http://www.w3.org/2000/01/rdf-schema#label> "1" .
<http://ctro/data#Arm_46555> <http://ctro/data#hasNumberPatientsArm> "162" .
<http://ctro/data#Arm_46555> <http://ctro/data#hasAdverseEffect> <http://ctro/data#Outcome_46628> .
<http://ctro/data#Arm_46555> <http://ctro/data#hasIntervention> <http://ctro/data#Intervention_46525> .
<http://ctro/data#Arm_46555> <http://ctro/data#hasOutcome> <http://ctro/data#Outcome_46596> .
<http://ctro/data#Arm_46555> <http://ctro/data#hasAdverseEffect> <http://ctro/data#Outcome_46687> .
<http://ctro/data#Arm_46555> <http://ctro/data#hasAdverseEffect> <http://ctro/data#Outcome_46747> .
<http://ctro/data#Arm_46568> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Arm> .
<http://ctro/data#Arm_46568> <http://www.w3.org/2000/01/rdf-schema#label> "2" .
<http://ctro/data#Arm_46568> <http://ctro/data#hasNumberPatientsArm> "79" .
<http://ctro/data#Arm_46568> <http://ctro/data#hasOutcome> <http://ctro/data#Outcome_46596> .
<http://ctro/data#Arm_46568> <http://ctro/data#hasAdverseEffect> <http://ctro/data#Outcome_46655> .
<http://ctro/data#Arm_46568> <http://ctro/data#hasIntervention> <http://ctro/data#Intervention_46531> .
<http://ctro/data#Arm_46568> <http://ctro/data#hasAdverseEffect> <http://ctro/data#Outcome_46714> .
<http://ctro/data#Arm_46568> <http://ctro/data#hasAdverseEffect> <http://ctro/data#Outcome_46774> .
# RDF export of group: Intervention
<http://ctro/data#Intervention_46525> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Intervention> .
<http://ctro/data#Intervention_46525> <http://www.w3.org/2000/01/rdf-schema#label> "lin" .
<http://ctro/data#Intervention_46525> <http://ctro/data#hasMedication> <http://ctro/data#Medication_46490> .
<http://ctro/data#Intervention_46525> <http://ctro/data#hasFrequency> "once - daily" .
<http://ctro/data#RelativeTime_46530> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#RelativeTime> .
<http://ctro/data#Intervention_46531> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Intervention> .
<http://ctro/data#Intervention_46531> <http://www.w3.org/2000/01/rdf-schema#label> "pla" .
<http://ctro/data#Intervention_46531> <http://ctro/data#hasMedication> <http://ctro/data#Medication_46497> .
<http://ctro/data#Intervention_46531> <http://ctro/data#hasFrequency> "once - daily" .
<http://ctro/data#RelativeTime_46536> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#RelativeTime> .
# RDF export of group: Medication
<http://ctro/data#Medication_46490> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Medication> .
<http://ctro/data#Medication_46490> <http://www.w3.org/2000/01/rdf-schema#label> "lin" .
<http://ctro/data#Medication_46490> <http://ctro/data#hasDrug> <http://ctro/data#Linagliptin> .
<http://ctro/data#Medication_46490> <http://ctro/data#hasDoseValue> "5" .
<http://ctro/data#Medication_46490> <http://ctro/data#hasDoseUnit> <http://ctro/data#mg> .
<http://ctro/data#Medication_46490> <http://ctro/data#hasDeliveryMethod> <http://ctro/data#Oral> .
<http://ctro/data#Medication_46497> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Medication> .
<http://ctro/data#Medication_46497> <http://www.w3.org/2000/01/rdf-schema#label> "pla" .
<http://ctro/data#Medication_46497> <http://ctro/data#hasDrug> <http://ctro/data#Placebo> .
<http://ctro/data#BioAndMedicalUnit_46500> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#BioAndMedicalUnit> .
<http://ctro/data#DeliveryMethod_46501> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#DeliveryMethod> .
# RDF export of group: Outcome
<http://ctro/data#Outcome_46596> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Outcome> .
<http://ctro/data#Outcome_46596> <http://www.w3.org/2000/01/rdf-schema#label> "hba 1" .
<http://ctro/data#Outcome_46596> <http://ctro/data#hasEndpoint> <http://ctro/data#Endpoint_46591> .
<http://ctro/data#Outcome_46596> <http://ctro/data#hasBaselineValue> "7 · 8" .
<http://ctro/data#Outcome_46596> <http://ctro/data#hasSdDevBL> "0 · 8" .
<http://ctro/data#Outcome_46596> <http://ctro/data#hasChangeValue> "0 · 64" .
<http://ctro/data#Outcome_46596> <http://ctro/data#hasPValueChangeValue> "p < 0 · 0001" .
<http://ctro/data#Outcome_46596> <http://ctro/data#hasConfIntervalChangeValue> "95 % CI - 0 · 81 to - 0 · 48" .
<http://ctro/data#Outcome_46596> <http://ctro/data#hasTimePoint> "week 24" .
<http://ctro/data#Outcome_46628> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Outcome> .
<http://ctro/data#Outcome_46628> <http://www.w3.org/2000/01/rdf-schema#label> "ae 1" .
<http://ctro/data#Outcome_46628> <http://ctro/data#hasEndpoint> <http://ctro/data#Endpoint_46623> .
<http://ctro/data#Outcome_46628> <http://ctro/data#hasNumberAffected> "123" .
<http://ctro/data#Outcome_46628> <http://ctro/data#hasPercentageAffected> "75 · 9" .
<http://ctro/data#Outcome_46655> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Outcome> .
<http://ctro/data#Outcome_46655> <http://www.w3.org/2000/01/rdf-schema#label> "ae 2" .
<http://ctro/data#Outcome_46655> <http://ctro/data#hasEndpoint> <http://ctro/data#Endpoint_46623> .
<http://ctro/data#Outcome_46655> <http://ctro/data#hasNumberAffected> "60" .
<http://ctro/data#Outcome_46655> <http://ctro/data#hasPercentageAffected> "75 · 9" .
<http://ctro/data#Outcome_46687> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Outcome> .
<http://ctro/data#Outcome_46687> <http://www.w3.org/2000/01/rdf-schema#label> "sae 1" .
<http://ctro/data#Outcome_46687> <http://ctro/data#hasEndpoint> <http://ctro/data#Endpoint_46682> .
<http://ctro/data#Outcome_46687> <http://ctro/data#hasNumberAffected> "14" .
<http://ctro/data#Outcome_46687> <http://ctro/data#hasPercentageAffected> "8 · 6" .
<http://ctro/data#Outcome_46687> <http://ctro/data#hasObservedResult> "none were deemed related to study drug" .
<http://ctro/data#Outcome_46714> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Outcome> .
<http://ctro/data#Outcome_46714> <http://www.w3.org/2000/01/rdf-schema#label> "sae 2" .
<http://ctro/data#Outcome_46714> <http://ctro/data#hasEndpoint> <http://ctro/data#Endpoint_46682> .
<http://ctro/data#Outcome_46714> <http://ctro/data#hasNumberAffected> "five" .
<http://ctro/data#Outcome_46714> <http://ctro/data#hasPercentageAffected> "6 · 3" .
<http://ctro/data#Outcome_46747> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Outcome> .
<http://ctro/data#Outcome_46747> <http://www.w3.org/2000/01/rdf-schema#label> "hyp 1" .
<http://ctro/data#Outcome_46747> <http://ctro/data#hasEndpoint> <http://ctro/data#Endpoint_46742> .
<http://ctro/data#Outcome_46747> <http://ctro/data#hasNumberAffected> "39" .
<http://ctro/data#Outcome_46747> <http://ctro/data#hasPercentageAffected> "24 · 1" .
<http://ctro/data#Outcome_46774> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Outcome> .
<http://ctro/data#Outcome_46774> <http://www.w3.org/2000/01/rdf-schema#label> "hyp 2" .
<http://ctro/data#Outcome_46774> <http://ctro/data#hasEndpoint> <http://ctro/data#Endpoint_46742> .
<http://ctro/data#Outcome_46774> <http://ctro/data#hasNumberAffected> "13" .
<http://ctro/data#Outcome_46774> <http://ctro/data#hasPercentageAffected> "16 · 5" .
# RDF export of group: DiffBetweenGroups
<http://ctro/data#DiffBetweenGroups_46801> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#DiffBetweenGroups> .
<http://ctro/data#DiffBetweenGroups_46801> <http://www.w3.org/2000/01/rdf-schema#label> "hyp" .
<http://ctro/data#DiffBetweenGroups_46801> <http://ctro/data#hasPvalueDiff> "p = 0 · 2083" .
<http://ctro/data#DiffBetweenGroups_46801> <http://ctro/data#hasConfIntervalDiff> "95 % CI 0 · 78 - 3 · 78" .
<http://ctro/data#DiffBetweenGroups_46801> <http://ctro/data#hasOutcome1> <http://ctro/data#Outcome_46747> .
<http://ctro/data#DiffBetweenGroups_46801> <http://ctro/data#hasOutcome2> <http://ctro/data#Outcome_46774> .
# RDF export of group: EvidenceQuality
<http://ctro/data#EvidenceQuality_92007> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#EvidenceQuality> .
<http://ctro/data#EvidenceQuality_92007> <http://www.w3.org/2000/01/rdf-schema#label> "EvidenceQuality 92007" .
<http://ctro/data#EvidenceQuality_92007> <http://ctro/data#isPharmacySponsored> "Boehringer Ingelheim" .